본문 바로가기

Antimicrobial Susceptibility of Stenotrophomonas maltophilia Isolates from Korea, and the Activity of Antimicrobial Combinations against the Isolates

문서 유형
연구출판물 · 학술지 논문
등재
KCISCIEScopus
저널 순위
JCR Q2Scopus Q3
저널
JOURNAL OF KOREAN MEDICAL SCIENCE28(1) · pp.62 · 2013
피인용
Web of Science 50KCI 3
JCR IF
JCR 2012 1.249
ISSN
1011-8934

저자

  1. 정혜선이화여자대학교
  2. 홍성근교신저자차의과학대학교
  3. 김영리제주대학교
  4. 신경섭충북대학교
  5. 황동희인제대학교
  6. 안지영순천향대학교
  7. 박연준가톨릭대학교
  8. 어영연세대학교
  9. 장철훈부산대학교
  10. 신종희전남대학교
  11. 이혜수전북대학교
  12. 이경원연세대학교
  13. Yunsop Chong연세대학교

초록

The aim of this study was to determine antimicrobial susceptibility of recent clinical Stenotrophomonas maltophilia isolates from Korea, and to compare the activity levels of several combinations of antimicrobials. A total of 206 non-duplicate clinical isolates of S. maltophilia was collected in 2010 from 11 university hospitals. Antimicrobial susceptibility testing was performed using the Clinical Laboratory Standards Institute agar dilution method. In vitro activity of antimicrobial combinations was tested using the checkerboard method. The susceptibility rates to trimethoprim-sulfamethoxazole and minocycline were 96% and 99%, respectively. The susceptibility rate to levofloxacin was 64%. All of four antimicrobial combinations showed synergy against many S. maltophilia isolates. A combination of trimethoprim-sulfamethoxazole plus ticarcillin-clavulanate was most synergistic among the combinations. None of the combinations showed antagonistic activity. Therefore, some of the combinations may be more useful than individual drugs in the treatment of S. maltophilia infection. Further clinical studies are warranted to validate our in vitro test results.

키워드

Stenotrophomonas maltophiliaCombination Drug TherapyTrimethoprim-SulfamethoxazoleTicarcillin-ClavulanateMULTIPLE ANTIBIOTIC-RESISTANCEIN-VITRO ACTIVITIESXANTHOMONAS-MALTOPHILIASURVEILLANCE PROGRAMCLINICAL STRAINSCYSTIC-FIBROSISTIGECYCLINEPATHOGENSYNERGYMULTICENTER

식별자

WoS UID
000314527100009
KCI
ART001737195